Data Management

Webinar Date/Time: Tuesday, June 25th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Six trends to help guide trial master file strategy.

A more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.

Companies must be able to defend the fidelity and confidentiality of all records and data generated throughout a product’s entire lifecycle, starting with the earliest points in research.

Promising scientific advances are pacing oncology drug development.

Webinar Date/Time: Tuesday, May 21st, 2024 at 2pm PDT | 5pm EDT | 11pm CEST

Despite the significance offered by AI to pharmaceutical companies, there are several challenges that must be overcome for successful integration of tech-based tools.

A look at the lessons learned from one platform approach to study enrollment tracking—and the wider quest for accountability in achieving diversity and inclusion goals.

In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.

In part 2 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses best practices for understanding specific therapeutic areas and deploying an effective eCOA strategy.

Factors that contribute to Japan's prominent position in the rapidly evolving field of digital therapeutics and why it matters to the global life sciences industry.

Harnessing advances in digital health technologies for a more precision-measured approach.

The potential of personal health records to bridge the gap between research and care.

Whether unstructured patient diaries will be part of future clinical trials depends on three main factors, including answers around added value.

Streamlining electronic clinical outcome assessment and patient-reported outcome processes can aid in decreasing timelines.

The current clinical development model is shifting toward a generative AI-augmented proactive approach supported by real-world data for real time evidence.

Spearheaded by disease foundations, the creation of clinical registries is streamlining data collection and driving informed decisions.

Webinar Date/Time: Thursday, May 9th, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Webinar Date/Time: Tuesday, May 7th, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Webinar Date/Time: Thursday, May 2nd, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

As clinical trials continue to advance and evolve to include real-world data, their success is becoming ever more dependent on the quality of data.

Webinar Date/Time: Tuesday, April 30, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Because of drastic changes in the clinical trial space, there is a need for advancing and streamlining design through risk-based methodologies and innovations.

Although there are much larger problems in clinical research, storing obsolete study records is a totally unnecessary cost.

Industry leaders discuss how technology can help companies adapt to the regulatory changes and accomplish their DE&I goals.

Exploring ways to boost the adoption of eCOA provider-specific libraries—an often-frustrating migration process, but one with significant payoffs in simplified workflows and reduced timelines.

The FDA has taken a clear position with Project Optimus in shifting toward more progressive tailored approaches while rejecting antiquated study designs to evolve clinical trial strategies to better align with newer drug classes.

Webinar Date/Time: Tue, Mar 26, 2024 11:00 AM EDT

Agency reports concerns amid an increase in submitted data that has been fabricated, duplicated, or unreliable from third-party laboratories.

Many companies have implemented new technologies and are adopting clinical trial models that are more patient-centric.